HEADER NUCLEOTIDYLTRANSFERASE 30-MAR-95 1HNV TITLE STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN TITLE 2 THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66); COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.49; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P51); COMPND 8 CHAIN: B; COMPND 9 EC: 2.7.7.49; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 8 ORGANISM_TAXID: 11676; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEOTIDYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.DAS,J.DING,E.ARNOLD REVDAT 4 07-FEB-24 1HNV 1 REMARK SEQADV REVDAT 3 24-FEB-09 1HNV 1 VERSN REVDAT 2 01-APR-03 1HNV 1 JRNL REVDAT 1 10-JUL-95 1HNV 0 JRNL AUTH J.DING,K.DAS,H.MOEREELS,L.KOYMANS,K.ANDRIES,P.A.JANSSEN, JRNL AUTH 2 S.H.HUGHES,E.ARNOLD JRNL TITL STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REVEALS JRNL TITL 2 SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE JRNL TITL 3 INHIBITORS. JRNL REF NAT.STRUCT.BIOL. V. 2 407 1995 JRNL REFN ISSN 1072-8368 JRNL PMID 7545077 JRNL DOI 10.1038/NSB0595-407 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.DING,K.DAS,C.TANTILLO,W.ZHANG,A.D.CLARK JUNIOR,S.JESSEN, REMARK 1 AUTH 2 X.LU,Y.HSIOU,A.JACOBO-MOLINA,K.ANDRIES,R.PAUWELS,H.MOEREELS, REMARK 1 AUTH 3 L.KOYMANS,P.A.J.JANSSEN,R.H.SMITH JUNIOR,M.K.KOEPKE, REMARK 1 AUTH 4 C.J.MICHEJDA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH REMARK 1 TITL 2 THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R95845 AT 2.8 REMARK 1 TITL 3 ANGSTROMS RESOLUTION REMARK 1 REF STRUCTURE V. 3 365 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.DING,A.JACOBO-MOLINA,C.TANTILLO,X.LU,R.G.NANNI,E.ARNOLD REMARK 1 TITL BURIED SURFACE ANALYSIS OF HIV-1 REVERSE TRANSCRIPTASE REMARK 1 TITL 2 P66(SLASH)P51 HETERODIMER AND ITS INTERACTION WITH DSDNA REMARK 1 TITL 3 TEMPLATE(SLASH)PRIMER REMARK 1 REF J.MOL.RECOG. V. 7 157 1994 REMARK 1 REFN ISSN 0952-3499 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.TANTILLO,J.DING,A.JACOBO-MOLINA,R.G.NANNI,P.L.BOYER, REMARK 1 AUTH 2 S.H.HUGHES,R.PAUWELS,K.ANDRIES,P.A.J.JANSSEN,E.ARNOLD REMARK 1 TITL LOCATIONS OF ANTI-AIDS DRUG BINDING SITES AND RESISTANCE REMARK 1 TITL 2 MUTATIONS IN THE THREE-DIMENSIONAL STRUCTURE OF HIV-1 REMARK 1 TITL 3 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR MECHANISMS OF DRUG REMARK 1 TITL 4 INHIBITION AND RESISTANCE REMARK 1 REF J.MOL.BIOL. V. 243 369 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.JACOBO-MOLINA,J.DING,R.G.NANNI,A.D.CLARK JUNIOR,X.LU, REMARK 1 AUTH 2 C.TANTILLO,R.L.WILLIAMS,G.KAMER,A.L.FERRIS,P.CLARK,A.HIZI, REMARK 1 AUTH 3 S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 1 TITL 2 REVERSE TRANSCRIPTASE COMPLEXED WITH DOUBLE-STRANDED DNA AT REMARK 1 TITL 3 3.0 ANGSTROMS RESOLUTION SHOWS BENT DNA REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 6320 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.G.NANNI,J.DING,A.JACOBO-MOLINA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL REVIEW OF HIV-1 REVERSE TRANSCRIPTASE THREE-DIMENSIONAL REMARK 1 TITL 2 STRUCTURE: IMPLICATIONS FOR DRUG DESIGN REMARK 1 REF PERSPECT.DRUG DISCOVERY DES. V. 1 129 1993 REMARK 1 REFN ISSN 0928-2866 REMARK 1 REFERENCE 6 REMARK 1 AUTH E.ARNOLD,A.JACOBO-MOLINA,R.G.NANNI,R.L.WILLIAMS,X.LU,J.DING, REMARK 1 AUTH 2 A.D.CLARK JUNIOR,A.ZHANG,A.L.FERRIS,P.CLARK,A.HIZI, REMARK 1 AUTH 3 S.H.HUGHES REMARK 1 TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE(SLASH)DNA COMPLEX REMARK 1 TITL 2 AT 7 ANGSTROMS RESOLUTION SHOWING ACTIVE SITE LOCATIONS REMARK 1 REF NATURE V. 357 85 1992 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 7 REMARK 1 AUTH A.JACOBO-MOLINA,A.D.CLARK JUNIOR,R.L.WILLIAMS,R.G.NANNI, REMARK 1 AUTH 2 P.CLARK,A.L.FERRIS,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTALS OF A TERNARY COMPLEX OF HUMAN IMMUNODEFICIENCY REMARK 1 TITL 2 VIRUS TYPE 1 REVERSE TRANSCRIPTASE WITH A MONOCLONAL REMARK 1 TITL 3 ANTIBODY FAB FRAGMENT AND DOUBLE-STRANDED DNA DIFFRACT REMARK 1 TITL 4 X-RAYS TO 3.5 ANGSTROMS RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 88 10895 1991 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.2 REMARK 3 NUMBER OF REFLECTIONS : 26249 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.356 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7812 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.930 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HNV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32514 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 113.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 113.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE DEFINITION OF SECONDARY STRUCTURAL ELEMENTS IS LARGELY REMARK 400 BASED ON PROGRAM PROCHECK AND HYDROGEN-BONDING PATTERN. REMARK 400 THE NAMES OF SECONDARY STRUCTURAL ELEMENTS WERE BASICALLY REMARK 400 KEPT CONSISTENT WITH THAT USED IN JACOBO-MOLINA ET AL. REMARK 400 (1993). SOME ASSIGNED BETA STRANDS DO NOT APPEAR TO REMARK 400 PARTICIPATE IN BETA SHEETS. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 36 CG CD OE1 OE2 REMARK 470 LYS A 66 CG CD CE NZ REMARK 470 TRP A 71 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 71 CZ3 CH2 REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 SER A 134 OG REMARK 470 ILE A 135 CG1 CG2 CD1 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 ASN A 137 CG OD1 ND2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 THR A 139 OG1 CG2 REMARK 470 TYR A 183 C O REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 HIS A 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 LEU A 282 CG CD1 CD2 REMARK 470 LEU A 283 CG CD1 CD2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 THR A 286 OG1 CG2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 THR A 290 OG1 CG2 REMARK 470 GLU A 291 CG CD OE1 OE2 REMARK 470 VAL A 292 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 GLU A 298 CG CD OE1 OE2 REMARK 470 GLU A 300 CG CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 GLU A 302 CG CD OE1 OE2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 GLU A 312 CG CD OE1 OE2 REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 MET A 357 CG SD CE REMARK 470 ARG A 358 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 366 CG CD CE NZ REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 ILE A 556 CG1 CG2 CD1 REMARK 470 ARG A 557 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 ASP B 121 CG OD1 OD2 REMARK 470 GLN B 197 CG CD OE1 NE2 REMARK 470 ARG B 199 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 220 CG CD CE NZ REMARK 470 GLN B 222 CG CD OE1 NE2 REMARK 470 LYS B 223 CG CD CE NZ REMARK 470 GLU B 224 CG CD OE1 OE2 REMARK 470 PRO B 225 CG CD REMARK 470 PRO B 226 CG CD REMARK 470 PHE B 227 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 228 CG CD1 CD2 REMARK 470 TRP B 229 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 229 CZ3 CH2 REMARK 470 MET B 230 CG SD CE REMARK 470 ILE B 270 CG1 CG2 CD1 REMARK 470 GLN B 278 CG CD OE1 NE2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 MET B 357 CG SD CE REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 361 CG ND1 CD2 CE1 NE2 REMARK 470 THR B 362 OG1 CG2 REMARK 470 ASN B 363 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD1 LEU A 92 NZ LYS B 22 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP B 153 CB TRP B 153 CG -0.119 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 134 N - CA - C ANGL. DEV. = 17.6 DEGREES REMARK 500 PRO A 313 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO A 345 C - N - CA ANGL. DEV. = 10.1 DEGREES REMARK 500 PRO B 19 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 PRO B 59 C - N - CA ANGL. DEV. = 12.4 DEGREES REMARK 500 PRO B 97 C - N - CA ANGL. DEV. = 10.9 DEGREES REMARK 500 MET B 184 CG - SD - CE ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 27.28 -79.57 REMARK 500 VAL A 21 98.00 -61.57 REMARK 500 PRO A 25 84.51 -44.75 REMARK 500 GLU A 29 -72.78 -52.44 REMARK 500 VAL A 35 -73.34 -71.04 REMARK 500 PRO A 52 -83.09 -75.40 REMARK 500 ASN A 54 79.98 -168.37 REMARK 500 ILE A 63 166.78 179.54 REMARK 500 ARG A 78 -38.08 -37.55 REMARK 500 VAL A 90 -80.96 -5.18 REMARK 500 LEU A 92 43.03 -84.96 REMARK 500 PRO A 97 -39.17 -33.67 REMARK 500 LEU A 100 171.32 -59.24 REMARK 500 THR A 107 146.02 -177.62 REMARK 500 ASP A 113 53.96 -102.32 REMARK 500 ALA A 114 -47.60 -26.40 REMARK 500 GLU A 122 -15.07 -44.52 REMARK 500 ARG A 125 -38.84 -38.57 REMARK 500 THR A 128 62.90 -109.26 REMARK 500 PRO A 140 8.64 -64.28 REMARK 500 ASN A 147 -30.93 -131.75 REMARK 500 SER A 156 -67.46 -28.05 REMARK 500 ASP A 177 54.24 -106.54 REMARK 500 SER A 191 -175.03 -175.64 REMARK 500 ASP A 192 54.16 -103.78 REMARK 500 ILE A 195 -55.36 -29.95 REMARK 500 THR A 200 -74.91 -57.97 REMARK 500 GLN A 222 103.25 -54.50 REMARK 500 MET A 230 54.71 38.38 REMARK 500 THR A 240 158.16 178.98 REMARK 500 GLN A 242 -33.30 -133.78 REMARK 500 LYS A 249 174.29 177.69 REMARK 500 SER A 251 52.83 79.82 REMARK 500 PRO A 272 98.71 -62.74 REMARK 500 ILE A 274 126.76 -38.66 REMARK 500 ARG A 277 -78.69 -44.35 REMARK 500 ARG A 284 10.67 -58.12 REMARK 500 LYS A 287 102.67 -58.90 REMARK 500 ALA A 288 31.63 -150.17 REMARK 500 PRO A 294 96.46 -66.88 REMARK 500 LEU A 303 -70.34 -46.83 REMARK 500 PRO A 321 -0.91 -53.08 REMARK 500 GLN A 334 -126.85 50.41 REMARK 500 PRO A 345 -51.14 -0.87 REMARK 500 ARG A 356 27.03 -66.14 REMARK 500 ARG A 358 -112.97 -20.41 REMARK 500 ALA A 360 -82.19 -141.54 REMARK 500 ILE A 393 138.95 -172.28 REMARK 500 PRO A 420 -104.38 -32.89 REMARK 500 TRP A 426 -80.46 -64.81 REMARK 500 REMARK 500 THIS ENTRY HAS 116 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR B 56 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 HET GROUP TIBO R 86183 IS TETRAHYDRO-IMIDAZO(4,5,1-KJ)(1,4- REMARK 600 BENZODIAZEPIN-2(1H)-ONE AND THIONE DERIVATIVE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TBO A 559 DBREF 1HNV A 1 558 UNP P03366 POL_HV1B1 599 1156 DBREF 1HNV B 1 427 UNP P03366 POL_HV1B1 599 1025 SEQADV 1HNV SER A 280 UNP P03366 CYS 447 CONFLICT SEQADV 1HNV SER B 280 UNP P03366 CYS 447 CONFLICT SEQRES 1 A 558 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 558 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 558 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 558 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 558 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 558 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 558 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 558 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 558 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 558 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 558 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 558 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 558 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 558 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 558 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 558 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 558 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 558 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 558 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 558 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 558 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 558 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 558 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 558 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 558 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 558 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 558 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 558 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 558 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 558 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 558 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 558 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 558 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 558 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 558 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 558 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 558 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 558 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 558 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 558 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 558 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 558 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 558 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS SEQRES 1 B 427 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 427 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 427 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 427 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 427 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 427 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 427 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 427 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 427 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 427 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 427 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 427 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 427 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 427 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 427 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 427 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 427 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 427 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 427 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 427 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 427 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 427 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 427 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 427 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 427 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 427 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 427 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 427 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 427 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 427 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 427 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 427 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 427 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR HET TBO A 559 21 HETNAM TBO 5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9- HETNAM 2 TBO TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE HETSYN TBO TBO 8; TIBO R86183 FORMUL 3 TBO C16 H20 CL N3 S HELIX 1 AA GLU A 28 GLU A 44 1 17 HELIX 2 AB ARG A 78 ARG A 83 1 6 HELIX 3 AC ALA A 114 SER A 117 1 4 HELIX 4 AD GLU A 122 TYR A 127 1 6 HELIX 5 AE LYS A 154 GLN A 174 1 21 HELIX 6 AF ILE A 195 TRP A 212 1 18 HELIX 7 AH VAL A 254 GLN A 269 1 16 HELIX 8 AI ARG A 277 LEU A 283 1 7 HELIX 9 AJ GLU A 297 LYS A 311 1 15 HELIX 10 AK ASP A 364 TRP A 383 1 20 HELIX 11 AL LYS A 395 GLU A 404 1 10 HELIX 12 A' ASN A 474 ASP A 488 1 15 HELIX 13 B' GLN A 500 ALA A 508 1 9 HELIX 14 D' GLU A 516 LYS A 527 1 12 HELIX 15 E' GLY A 544 ALA A 554 1 11 HELIX 16 BA GLU B 28 GLU B 44 1 17 HELIX 17 BB ARG B 78 VAL B 90 1 13 HELIX 18 BC GLY B 112 SER B 117 1 6 HELIX 19 BD GLU B 122 THR B 128 1 7 HELIX 20 BE LYS B 154 GLN B 174 1 21 HELIX 21 BF ILE B 195 TRP B 212 1 18 HELIX 22 BH VAL B 254 ILE B 270 1 17 HELIX 23 BI ARG B 277 LEU B 283 1 7 HELIX 24 BJ GLU B 297 LYS B 311 1 15 HELIX 25 BK ASP B 364 TRP B 383 1 20 HELIX 26 BL LYS B 395 TYR B 405 1 11 SHEET 1 S1 3 ILE A 47 ILE A 50 0 SHEET 2 S1 3 ILE A 142 TYR A 146 -1 SHEET 3 S1 3 THR A 128 ILE A 132 -1 SHEET 1 S2 2 ASN A 57 LYS A 64 0 SHEET 2 S2 2 ARG A 72 PHE A 77 -1 SHEET 1 S3 3 SER A 105 VAL A 111 0 SHEET 2 S3 3 ASP A 186 SER A 191 -1 SHEET 3 S3 3 ILE A 178 TYR A 183 -1 SHEET 1 S4 4 PHE A 227 TRP A 229 0 SHEET 2 S4 4 TYR A 232 HIS A 235 -1 SHEET 3 S4 4 LYS A 238 VAL A 241 -1 SHEET 4 S4 4 VAL A 314 ASP A 320 -1 SHEET 1 S5 5 LYS A 347 ARG A 356 0 SHEET 2 S5 5 GLN A 336 TYR A 342 -1 SHEET 3 S5 5 LEU A 325 GLN A 332 -1 SHEET 4 S5 5 PRO A 387 LEU A 391 1 SHEET 5 S5 5 GLU A 413 THR A 419 1 SHEET 1 S6 5 GLY A 462 THR A 470 0 SHEET 2 S6 5 LEU A 452 THR A 459 -1 SHEET 3 S6 5 GLU A 438 ASN A 447 -1 SHEET 4 S6 5 GLU A 492 THR A 497 1 SHEET 5 S6 5 LYS A 530 VAL A 536 1 SHEET 1 S7 3 ILE B 47 GLY B 51 0 SHEET 2 S7 3 ILE B 142 TYR B 146 -1 SHEET 3 S7 3 ALA B 129 ILE B 132 -1 SHEET 1 S8 2 TYR B 56 LYS B 64 0 SHEET 2 S8 2 TRP B 71 ASP B 76 -1 SHEET 1 S9 3 SER B 105 ASP B 110 0 SHEET 2 S9 3 ASP B 186 SER B 191 -1 SHEET 3 S9 3 ILE B 178 TYR B 183 -1 SHEET 1 S10 5 LYS B 347 ARG B 356 0 SHEET 2 S10 5 GLN B 336 TYR B 342 -1 SHEET 3 S10 5 LEU B 325 LYS B 331 -1 SHEET 4 S10 5 PRO B 387 LEU B 391 1 SHEET 5 S10 5 GLU B 413 VAL B 417 1 SITE 1 AC1 7 LEU A 100 LYS A 101 VAL A 179 TYR A 181 SITE 2 AC1 7 TYR A 188 TRP A 229 TYR A 318 CRYST1 227.200 70.200 105.700 90.00 105.60 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004401 0.000000 0.001229 0.00000 SCALE2 0.000000 0.014245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009823 0.00000